Core Molding Technologies, Inc. (NYSEAMERICAN:CMT - Get Free Report) CEO David L. Duvall sold 9,000 shares of Core Molding Technologies stock in a transaction that occurred on Wednesday, June 4th. The shares were sold at an average price of $16.02, for a total transaction of $144,180.00. Following the completion of the transaction, the chief executive officer now owns 239,780 shares of the company's stock, valued at $3,841,275.60. This trade represents a 3.62% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.
Core Molding Technologies Trading Up 0.2%
CMT traded up $0.03 on Friday, hitting $16.05. 39,403 shares of the company were exchanged, compared to its average volume of 39,066. The business has a 50-day moving average price of $15.41. The company has a current ratio of 2.41, a quick ratio of 1.98 and a debt-to-equity ratio of 0.14. Core Molding Technologies, Inc. has a twelve month low of $12.25 and a twelve month high of $19.20. The stock has a market capitalization of $143.81 million, a P/E ratio of 9.07 and a beta of 1.74.
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in CMT. Deutsche Bank AG lifted its stake in Core Molding Technologies by 99.2% during the fourth quarter. Deutsche Bank AG now owns 6,380 shares of the industrial products company's stock worth $106,000 after purchasing an additional 3,177 shares during the last quarter. GAMMA Investing LLC raised its stake in Core Molding Technologies by 38,585.0% during the 1st quarter. GAMMA Investing LLC now owns 7,737 shares of the industrial products company's stock worth $118,000 after acquiring an additional 7,717 shares in the last quarter. Barclays PLC lifted its position in Core Molding Technologies by 14.3% in the fourth quarter. Barclays PLC now owns 11,368 shares of the industrial products company's stock valued at $188,000 after acquiring an additional 1,426 shares during the last quarter. Stoneridge Investment Partners LLC acquired a new position in Core Molding Technologies in the fourth quarter valued at $189,000. Finally, White Pine Capital LLC acquired a new position in Core Molding Technologies in the fourth quarter valued at $256,000. Hedge funds and other institutional investors own 58.79% of the company's stock.
Analyst Upgrades and Downgrades
Separately, Roth Capital set a $22.00 price target on shares of Core Molding Technologies in a research note on Wednesday, March 12th.
Get Our Latest Report on Core Molding Technologies
Core Molding Technologies Company Profile
(
Get Free Report)
Core Molding Technologies, Inc, together with its subsidiaries, operates as a molder of thermoplastic and thermoset structural products. The company offers a range of manufacturing processes that include compression molding of sheet molding compound, resin transfer molding, liquid molding of dicyclopentadiene, spray-up and hand-lay-up, direct long-fiber thermoplastics, and structural foam and structural web injection molding.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Core Molding Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Molding Technologies wasn't on the list.
While Core Molding Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
